ElderTech companies face a GTM problem most playbooks were not built for: multi-stakeholder buyers, category education, accessibility requirements, and institutional sales cycles that outlast a typical startup runway. A fractional CXO brings that senior leadership without the cost of a full-time hire.
The Problem
Your founding team built the product but can't build the market
Most eldertech founders have clinical, engineering, or caregiving backgrounds. They built a product that solves a real problem for aging populations, but building a product and building a market are different disciplines. Marketing, sales, and partnership strategy for an eldertech company require someone who has run that playbook before – and your team is learning it live, on your runway.
You're selling to three audiences simultaneously with no playbook for any of them
ElderTech companies sell to older adults, family caregivers, and institutional buyers – each with different motivations, decision processes, and price sensitivity. A one- or two-person marketing team cannot build three separate go-to-market motions at once. Without someone senior deciding which audience drives growth first, resources get spread too thin to win any of them.
Institutional sales cycles require a level of sophistication you haven't built yet
Health systems, PACE programs, senior living operators, and Medicare Advantage plans run procurement processes built for enterprise vendors, not startups. They want clinical evidence, security and privacy audits, compliance documentation, and references before they sign. A founder pitch deck and a product demo do not clear that bar – you need someone who has sold into regulated healthcare buyers before.
Investors want a growth story and you're still writing the first chapter
Your board wants a clear path from current revenue to the next milestone: defined ICPs, channels that scale, predictable pipeline, and unit economics that improve quarter over quarter. Without a growth executive who can build that narrative from real data, fundraising conversations stall on questions about commercial maturity, not product quality.
How We Help
A fractional CXO from Winston Francois operates as your part-time growth executive: attending leadership meetings, directing your marketing team, reporting to your board, and owning commercial strategy. For eldertech, this role matters more than most verticals because the go-to-market problem is genuinely three-dimensional, not one buyer with three personas.
The first phase is diagnostic. We assess product-market fit across each audience segment, audit your current marketing and sales infrastructure, and identify the highest-leverage growth opportunity. In eldertech this usually means making a call most founding teams avoid: which buyer segment to prioritize first, when every segment feels equally urgent.
Once priorities are set, we build the growth strategy – positioning and messaging for the priority segment, channel selection, sales enablement for institutional buyers, and the reporting cadence to track what is actually working. We direct your existing team, manage agency relationships, and bring in Winston Francois specialists where you have a capability gap, rather than growing your headcount to cover it.
Brand positioning is part of this, not a separate project. We only invest in it because clear positioning shortens institutional sales cycles – a health system or PACE program evaluator needs to understand what you are and why it matters to them in under a minute, and most eldertech sites still read like a pitch deck.
We also build the measurement infrastructure that tells you which channel and which segment is actually producing pipeline, and we handle the organizational build-out as you grow: when to make the first full-time growth hire and how to transition out of the fractional model. A number of our engagements end with recruiting and onboarding the permanent CMO.
Every decision here is judged by its effect on pipeline and revenue, not activity volume. We do not run a campaign because the calendar says so – we run it because it moves a specific number.
What we deliver
- Growth diagnostic and 90-day prioritized plan – what to focus on first across your multi-segment market
- Growth strategy and execution leadership – directing your team, agencies, and specialist support
- Institutional sales enablement – materials and process for enterprise healthcare procurement
- Board reporting and investor narrative – growth activity translated into metrics that build confidence
- Organizational design and hiring plan – the marketing team you'll need at your next stage
ElderTech companies that try to sell consumers, caregivers, and institutions at the same time, before winning decisively in one segment, almost always stall. The fractional CXO's real job is often the uncomfortable call on which audience to deprioritize – and getting the rest of leadership aligned on it.
Our Methodology
Our fractional CXO engagements run on a 90-day sprint. The first 30 days are discovery: we audit your marketing, interview customers and prospects, review competitive positioning, assess pipeline, and evaluate team capability. You get a growth strategy document with a prioritized plan and clear success metrics.
Days 30-60 are execution and infrastructure. We implement the top-priority initiatives, set operating rhythms (weekly standups, biweekly leadership syncs, monthly board reports), and stand up the reporting to track what is working. For eldertech this means building the institutional sales toolkit alongside consumer or caregiver acquisition, in parallel.
Days 60-90 are optimization. With campaigns live and process in place, we measure against targets and adjust. This is where the fractional model earns its cost: strategic course correction from someone who has run this before, not more activity from a team without direction.
How We Work
A fractional CXO works 2-3 days a week with your team: leadership meetings, marketing standups, vendor management, and the strategic work that actually moves pipeline. We stay reachable through the week – this isn't a consulting engagement where we vanish between calls.
The first 30 days need full access: CRM, analytics, product roadmap, board decks, and introductions to key customers. The diagnostic is only as good as the data behind it.
From month two we settle into a steady rhythm: weekly team direction, biweekly strategy review with the CEO, monthly board reporting, and ongoing campaign management.
Most engagements run 6-12 months. Some companies need fractional leadership through their next raise; others use it to build the foundation, then hire full-time. When that time comes, we help define the role, recruit candidates, and manage the handoff.
- Focused growth strategy with clear audience prioritization
- Institutional sales readiness for healthcare and senior living buyers
- Board-ready growth metrics and narrative
- Marketing team development and eventual full-time leadership hire
If your eldertech / agetech company needs fractional cxo leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a fractional CXO cost for an eldertech company?
Monthly fees run $15K-$30K for 2-3 days a week of senior leadership, roughly a third of the fully loaded cost of a full-time CMO. For eldertech companies between Series A and Series B this is usually the right level of investment. Scope moves the number within that range.
How does a fractional CXO help with institutional sales in eldertech?
Institutional healthcare buyers – health systems, PACE programs, senior living chains, Medicare Advantage plans – run procurement most startup teams have never navigated. A fractional CXO who has been through those cycles builds the right sales materials, establishes the credibility signals, and guides your sales team through evaluation and security review. That means clinical evidence packaging, compliance documentation, and reference programs, built in sequence.
How is a fractional CXO different from hiring a marketing agency?
An agency executes tactics: ads, content, a website. A fractional CXO sets the strategy that decides which tactics matter, in what order, with what budget, and then manages your team and agencies against it. They also own the board relationship and the organizational calls that shape where the company is in a year.
What makes Winston Francois different for eldertech fractional CXO work?
We work at the intersection of healthtech, consumer, and B2B, which is exactly where eldertech sits. Most fractional CMOs come from purely consumer or purely enterprise backgrounds; eldertech needs both – consumer empathy for the end user and institutional selling skill for the health system buyer. Our team has operated inside regulated health verticals with the multi-stakeholder dynamics specific to aging services.
How long should we plan on needing a fractional CXO?
Most eldertech companies need 6-12 months of fractional leadership. The first 3 months build the strategic foundation and growth infrastructure; months 4-6 prove the model with real pipeline and revenue data. After that, most companies are ready for a full-time growth leader, and we help recruit, evaluate, and onboard that person.
What stage of eldertech company is the right fit?
Post-product, pre-scale: typically $1M-$20M in revenue with real customer traction but no repeatable growth engine yet. If you are still in R&D with no customers, a fractional CXO is premature. If you are past $30M with an established marketing team, you need a full-time CMO, not a fractional one – the fit is proving the business now that the product works.
